Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-013691

Director acquired 4,350 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2024-07-01 Other acquisition 10b5-1 +221 $1.47 $325 243,778 D: show line 1 in the form
Krogulski Kenneth Director 2024-07-02 Other acquisition 10b5-1 +221 $1.48 $327 243,999 D: show line 2 in the form
Krogulski Kenneth Director 2024-07-03 Other acquisition 10b5-1 +268 $1.52 $407 244,267 D: show line 3 in the form
Krogulski Kenneth Director 2024-07-05 Other acquisition 10b5-1 +221 $1.50 $332 244,488 D: show line 4 in the form
Krogulski Kenneth Director 2024-07-08 Other acquisition 10b5-1 +221 $1.49 $329 244,709 D: show line 5 in the form
Krogulski Kenneth Director 2024-07-09 Other acquisition 10b5-1 +221 $1.50 $332 244,930 D: show line 6 in the form
Krogulski Kenneth Director 2024-07-10 Other acquisition 10b5-1 +221 $1.50 $332 245,151 D: show line 7 in the form
Krogulski Kenneth Director 2024-07-11 Other acquisition 10b5-1 +221 $1.47 $325 245,372 D: show line 8 in the form
Loading xslF345X05/marketforms-66717.xml…